MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
12 hedge funds and large institutions have $1.26M invested in Stealth BioTherapeutics Corp. ADS in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
$138K |
| 2 |
Two Sigma Advisers
New York
|
$35K |
| 3 |
SBL
Sargent Bickham Lagudis
Boulder,
Colorado
|
$23K |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
$18.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
$24K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
$128K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
$0 |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
$761K |
| 4 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
Squarepoint
New York
|
$0 |
